Christina Kay
2019
In 2019, Christina Kay earned a total compensation of $205K as Co, Chief Executive Officer Executive Vice President at Integrated Biopharma, a 10% increase compared to previous year.
Compensation breakdown
| Option Awards | $18,884 |
|---|---|
| Salary | $179,302 |
| Other | $6,818 |
| Total | $205,004 |
Kay received $179.3K in salary, accounting for 87% of the total pay in 2019.
Kay also received $18.9K in option awards and $6.8K in other compensation.
Rankings
In 2019, Christina Kay's compensation ranked 13,431st out of 13,971 executives tracked by ExecPay. In other words, Kay earned more than 3.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 13,431 out of 13,971 | 4th |
Division Manufacturing | 5,457 out of 5,695 | 4th |
Major group Chemicals And Allied Products | 2,120 out of 2,194 | 3rd |
Industry group Drugs | 1,820 out of 1,880 | 3rd |
Industry Pharmaceutical Preparations | 1,347 out of 1,392 | 3rd |
Source: SEC filing on October 28, 2019.
Kay's colleagues
We found three more compensation records of executives who worked with Christina Kay at Integrated Biopharma in 2019.
News
Integrated Biopharma CFO Dina Masi's 2024 pay rises 8% to $357K
October 28, 2024
Integrated Biopharma CFO Dina Masi's 2023 pay rises 10% to $330K
October 27, 2023
Integrated Biopharma CFO Dina Masi's 2022 pay rises 12% to $300K
October 27, 2022
Integrated Biopharma CFO Dina Masi's 2021 pay rises 6% to $268K
October 27, 2021
Integrated Biopharma CFO Dina Masi's 2019 pay rises 4% to $251K
October 28, 2019